Merck & Co. Inc.
MRK | NYSE
$149.52
+$3.19 (+2.18%)
At close: Oct 30, 2026, 4:02 PM ET
$150.19
+$0.67 (+0.45%)
Pre-market:
Nov 2, 2026, 5:28 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 14.42 | 14.72 | 778.71 | 19.36 | 14.85 | 27.96 |
PEG Ratio | 1.81 | 0 | -7.98 | 1.75 | 0.17 | -1.02 |
PS Ratio | 4.06 | 3.93 | 4.62 | 4.74 | 3.98 | 4.75 |
PB Ratio | 5.01 | 5.44 | 7.39 | 6.11 | 5.08 | 7.79 |
P/FCF Ratio | 21.31 | 13.92 | 30.37 | 19.10 | 20.07 | 33.88 |
P/OCF Ratio | 15.99 | 11.73 | 21.35 | 14.71 | 13.74 | 19.25 |
OCF/S Ratio | 25.37 | 33.46 | 21.64 | 32.21 | 28.97 | 24.70 |
Debt / Equity Ratio | 0.96 | 0.83 | 0.97 | 0.70 | 0.91 | 1.32 |
Quick Ratio | 1.30 | 1.15 | 1 | 1.23 | 1.02 | 0.81 |
Current Ratio | 1.54 | 1.36 | 1.25 | 1.47 | 1.27 | 1.02 |
Asset Turnover | 0.47 | 0.55 | 0.56 | 0.54 | 0.46 | 0.45 |
Interest Coverage | 17.31 | 15.91 | 2.58 | 19 | 16.38 | 6.68 |
Return on Equity | 34.70% | 36.96% | 0.97% | 31.57% | 34.17% | 27.91% |
Return on Assets | 13.34% | 14.62% | 0.34% | 13.30% | 12.35% | 7.72% |
Return on Invested Capital | 18.27% | 18.97% | 0.71% | 18.53% | 13.90% | 6.03% |
Dividend Yield | 3.10% | 3.11% | 2.68% | 2.50% | 3.41% | 3.15% |
Payout Ratio | 44.79% | 45.80% | 2.04K% | 48.30% | 50.66% | 87.94% |
FCF Payout Ratio | 66.15% | 45.23% | 87.61% | 49.50% | 71.99% | 115.46% |
Gross Profit Margin | 71.98% | 76.32% | 73.17% | 70.63% | 72.02% | 67.20% |
Net Profit Margin | 28.12% | 26.68% | 0.61% | 24.49% | 26.79% | 17.02% |
Pretax Profit Margin | 32.45% | 31.07% | 3.14% | 27.74% | 28.50% | 14.12% |
Operating Profit Margin | 36.17% | 31.51% | 4.91% | 30.84% | 27.10% | 13.36% |
FCF Margin | 19.04% | 28.20% | 15.21% | 24.81% | 19.84% | 14.03% |
EBITDA Margin | 43.53% | 40.06% | 11.49% | 35.95% | 36.75% | 24.52% |
Add to Watchlist
Select watchlists to add or remove MRK